Electronic Prescriptions for Controlled Substances
EPCS Public Meeting
July 11-12, 2006
Arlington, VA
On Tuesday July 11, and Wednesday, July 12, 2006, the Drug Enforcement Administration (DEA), in conjunction with the Department of Health and Human Services (HHS), conducted a public meeting to discuss electronic prescriptions for controlled substances. Specifically, this meeting was intended to allow industry—prescribers, pharmacies, software/hardware vendors, and other interested third parties—to address how electronic prescribing systems can meet DEA’s prescription requirements under the Controlled Substances Act, and HHS’ statutory mandate to facilitate adoption of electronic prescribing under Part D of the Medicare Modernization Act, without unduly burdening the parties to electronic prescribing transactions. This meeting included six panel discussions focused on specific areas of expertise and interest. Panels included:
See below for all PowerPoint presentations and written remarks provided to DEA for dissemination.
Any questions regarding the conference may be directed to Liaison and Policy Section, at (202) 307-7297.
Opening Remarks
Department of Health and Human Services
Drug Enforcement Administration
Technical Framework Panel
- Steve Bruck, President, BruckEdwards, Inc. (PowerPoint)
- Donna Dodson, Computer Scientist, National Institute of Standards and Technology (PowerPoint)
- Mark Gingrich, Vice President, Information Technology, RxHub, LLC (PowerPoint)
- Rick Ratliff, Chief Executive Officer, SureScripts
- Terry Zagar, former Acting Chief Technology Officer, SAFE-BioPharma Association
Practitioner Perspectives Panel
- Mureen Allen, MBBS, MS, MA, MD, Senior Associate, Informatics and Practice Improvement, American College of Physicians (PowerPoint)
- Anita Everett, MD, DFAPA, Senior Medical Advisor, HHS Substance Abuse and Mental Health Services Administration
- John Huffman, MD, Holy Cross Pain Management, American Society of Anesthesiologists
- Robert Tennant, Senior Policy Advisor, Government Relations, Medical Group Management Association (Written Remarks)
- Alan Zuckerman, MD, FAAP, Council on Clinical Information Technology, American Academy of Pediatrics, Primary Care Informatics Program Director, Georgetown University (PowerPoint)
Pharmacy Perspectives Panel
- Paul Baldwin, Executive Director, Long Term Care Pharmacy Alliance
- Colleen Brennan, RPh, Director, Professional and Educational Affairs, National Community Pharmacists Association (PowerPoint)
- Lynne Gilbertson, Director, Standards Development, National Council of Prescription Drug Programs (PowerPoint)
- Calvin Knowlton, RPh, MDiv, PhD, American Pharmacists Association (PowerPoint)
- Kevin Nicholson, RPh, JD, Vice President, Pharmacy Regulatory Affairs, National Association of Chain Drug Stores
Vendor Perspectives Panel
State Perspectives Panel
- Adele Audet, Vice President, Alliance of States with Prescription Monitoring Programs
- Danna Droz, Chair, Executive Committee, National Association of State Controlled Substances Authorities (Written Remarks)
- Charisse Johnson, Professional Affairs Manager, National Association of Boards of Pharmacy (PowerPoint)
- Lisa Robin, Vice President, Leadership and Legislative Services, Federation of State Medical Boards
Law Enforcement Perspectives Panel
|
